University of Iowa and Holden Comprehensive Cancer Center

Iowa City, Iowa 52242

1 studies enrolling now · 2 studies all time

What they study most

Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Castration Resistant Prostate Cancer (mCRPC), Recurrence

Studies at this site

• AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC) — Recruiting now
• AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC) — Running, not enrolling